Trump's NHS Trade Deal Bombshell Exposed
Exclusive investigation reveals Donald Trump's plans to put NHS on the table in US trade negotiations, raising alarm about drug prices and American corporate influence on Britain's healthcare system.
Category : Search result: pharmaceutical tariffs
Trump Tariffs Threaten NHS Drug Price Crisis
Former President Donald Trump's proposed tariffs could dramatically increase costs for NHS medicines, potentially costing the health service billions and threatening patient care across the UK.
RFK Jr's Bizarre Ozempic Sugar Conspiracy Theory
Independent presidential candidate Robert F. Kennedy Jr has sparked controversy by suggesting diabetes and weight-loss medications like Ozempic are part of a conspiracy to eliminate sugar from American diets. His unconventional claims about artificial swe
Trump Tariffs Threaten NHS Drug Price Crisis
Exclusive investigation reveals how proposed US import tariffs could send NHS drug costs soaring, potentially creating treatment delays and budget crises for Britain's healthcare system.
Eight children die from contaminated cough syrup in India
Shocking investigation reveals eight young children died after consuming contaminated cough syrup in India's Madhya Pradesh region, raising serious questions about pharmaceutical safety standards.
NHS drug bill may rise £1bn due to Trump tariffs
Exclusive investigation reveals how potential Trump tariffs could devastate NHS medicine budgets while pharmaceutical giants reconsider UK investments over pricing disputes.
Ozempic may hide cancer in medical scans, experts warn
Groundbreaking research reveals popular GLP-1 medications including Ozempic may interfere with crucial cancer screenings by altering how organs appear on medical scans.
Spain Legalises Medical Cannabis Under Strict Rules
Spain joins European nations embracing medical cannabis as parliament approves landmark legislation for chronic pain, multiple sclerosis and chemotherapy side effects, with tight government controls.
AstraZeneca threatens UK investment over NHS drug prices
Pharmaceutical giant AstraZeneca threatens to slash billions in UK investment unless incoming Labour government agrees to significant NHS drug price increases, creating early crisis for Keir Starmer.
India seizes contaminated cough syrup after child deaths
Indian drug regulators have confiscated 50,000 bottles of Coldrif cough syrup in Madhya Pradesh following the deaths of at least six children, with laboratory tests revealing dangerous contamination levels.
RFK Jr's Radical Healthcare Overhaul: Patient Over Profit
Robert F Kennedy Jr unveils controversial healthcare manifesto promising to dismantle corporate medicine and prioritise patient wellbeing over profits in bold election pledge.
Trump's $17 Trillion Tariff Plan Under Fire
Former President Donald Trump's controversial proposal to impose universal 10% tariffs on all imports could trigger the largest tax increase in modern history, raising serious concerns among economists and trade experts.
Toxic cough syrup suspected in India child deaths
Indian health authorities investigate contaminated cough syrup as potential cause behind mysterious illness outbreak that has claimed multiple young lives, raising urgent questions about pharmaceutical safety standards.
AstraZeneca faces NY Medicaid exclusion in pricing clash
Pharmaceutical giant AstraZeneca could be blocked from New York's Medicaid programme following a White House meeting failure over the US paying significantly more for drugs than other nations.
Trump's Pfizer Deal Aims to Slash US Drug Prices
Former President Donald Trump announces groundbreaking agreement with Pfizer to slash prescription drug costs, vowing to overhaul US healthcare system if re-elected.
Big Pharma's Legal War Threatens NHS Drug Access
Pharmaceutical giants are launching an unprecedented legal assault against the UK government, threatening NHS access to vital medicines and putting patient care at risk in a battle over drug pricing.
Pfizer sued Medicaid for $105M during COVID vaccine rollout
Pharmaceutical giant Pfizer pursued a staggering $105 million Medicaid reimbursement lawsuit against the Trump administration while seeking regulatory approval for its COVID-19 vaccine, reveals explosive court documents.
Weight-Loss Jabs: The Profit-Driven Health Crisis
Exclusive investigation reveals how drug companies are profiting from body shame through Ozempic and Wegovy injections, while eating disorder experts warn of potentially devastating health consequences.
GSK's Growth Gamble: Walmsley's Steady Hand Faces Test
Five years into her tenure, CEO Emma Walmsley has stabilised GSK's ship, but looming patent cliffs and vaccine market pressures cast shadows over ambitious growth targets.
Six-month HIV prevention jab for 120 countries by 2027
A groundbreaking HIV prevention injection offering six months of protection with lenacapavir will be available in 120 lower-income countries by 2027 through a landmark access agreement.
UK Worst in Europe for Drug Prices, Says Eli Lilly
Eli Lilly accuses the UK of having Europe's most challenging drug pricing system, threatening patient access to new medicines like Mounjaro amid ongoing NHS negotiations.
Gold Prices Surge as Pharma Stocks Face Pressure
Financial markets experienced significant volatility as gold hit record highs while pharmaceutical giant Eli Lilly faced pressure over drug pricing concerns. Get the latest analysis on today's market movements.
Trump's Tylenol Gaffe Sends Wall Street into Frenzy
Former President Donald Trump's confusion between Tylenol and hydroxychloroquine during the presidential debate triggers a sharp sell-off in pharmaceutical stocks, with Kenvue shares taking a significant hit.
Business Chiefs Sound Alarm Over Trump's 10% Tariff Plan
Top US CEOs issue stark warnings as Donald Trump proposes sweeping 10% universal tariffs, threatening a new global trade war and price hikes for consumers.
Tylenol makers hit back at Trump's vaccine comparison
Pharmaceutical giant Kenvue has issued a stern rebuke to Donald Trump after he suggested the COVID-19 vaccine was comparable to the Tylenol murders, calling the analogy 'irresponsible'.
Chinese Executive Jailed in US Fentanyl Case
A senior Chinese pharmaceutical executive has been sentenced to 15 years in a US prison for conspiring to manufacture and distribute fentanyl, marking a significant victory in the transatlantic fight against the opioid crisis.
Trump Tariffs Threaten Halloween Candy and Costume Prices
Former President Donald Trump's proposed 10% tariff on all imports could send the price of Halloween costumes, decorations, and candy soaring, industry leaders warn, threatening a chilling effect on the annual celebration.
US Court Strikes Down Trump Tariffs as Unconstitutional
A landmark US court ruling has struck down Donald Trump's signature tariffs on foreign steel and aluminium, declaring them an unconstitutional overreach of presidential power. The decision sends shockwaves through global markets and UK trade policy.
NHS Drug Pricing: The Art of the Deal Saving Millions
Exclusive insight into how NHS England's shrewd negotiation tactics secure massive discounts on vital medicines, from cancer treatments to rare disease drugs, ensuring sustainable healthcare funding.
New Weight Loss Pill Cuts Body Weight By 20%
Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.
Page 1 of 4